Thankful for Jillian and Jillian’s lawyers and all of their hard work in providing the “landmark” QCH hospital statement.
An important area of enquiry is one of the complaints relating to Dr Amos’s concerns about male lactation. When AHPRA decided no further action re Dr Spenser an individual Australian activist declared “for now” re Dr Spencer - what on earth could he be meaning by that?
Multiple studies indicate that 95% to 98% of children who commence puberty blockers (PBs) will subsequently progress to cross-sex hormones.
Against this background, I compared reported rates of puberty-blocker initiation among young people attending gender services in the United States, United Kingdom and Australia.
• United States: In a four-year study of 926 adolescents just 5.1% commenced puberty blockers.
• United Kingdom: Puberty blockers are now restricted to formal clinical trials.
• Australia: Royal Children’s Hospital (RCH) data indicate that approximately 23–29% of evaluated young people commenced puberty blockers.
If the proposition that 95–98% of those who commence puberty blockers subsequently progress to cross-sex hormones is correct, the substantially higher rate of puberty-blocker initiation reported by RCH would logically imply a correspondingly much higher rate of subsequent cross-sex hormone treatment than that seen in other international gender facilities.
Probably the most serious inherent risk in taking a prepubertal child to a gender clinic for assessment of his/her wish to undergo gender transition.
There are two distinct variables of children in relation to their gender preference as they approach puberty:
• Those who continue to want to change gender at puberty, persisters (PS)
• Those who cease to wish to change their gender as they approach puberty, decisters (DS)
Some 70-90% of children, if left alone, will spontaneously desist as they approach puberty no longer wanting to change their gender.
It would be a disaster for a potential DS to undergo gender transition prior to puberty.
Clearly Gender Physicians must ensure that a child presenting with Gender Dysphoria and seeking Gender Transition is not one of the 70-90% of the cohort that would spontaneously desist as he/she approached puberty.
Obviously, the RCH is aware of the DS,PS cohorts challenfe and claim that they can identify the DS and not commence them in puberty blockers and subsequently cross sex hormones.
That would solve the problem if it were true, however the methodology by which RCH makes these important decisions had not received global acceptance.
• The findings of the Cass Review profoundly challenge the evidentiary basis for the RCH's claimed ability to identify PSers (those who remain trans into adulthood) and DSers (those whose gender confusion resolves).
• Independent psychiatric experts point out that there are zero validated psychological tests, objective biomarkers, or diagnostic tools capable of predicting an individual child’s long-term gender trajectory.
Jillian has helped us all
Hope so.
Thankful for Jillian and Jillian’s lawyers and all of their hard work in providing the “landmark” QCH hospital statement.
An important area of enquiry is one of the complaints relating to Dr Amos’s concerns about male lactation. When AHPRA decided no further action re Dr Spenser an individual Australian activist declared “for now” re Dr Spencer - what on earth could he be meaning by that?
They identify as vindictive.
RCH PUBERTY BLOCKERS
Multiple studies indicate that 95% to 98% of children who commence puberty blockers (PBs) will subsequently progress to cross-sex hormones.
Against this background, I compared reported rates of puberty-blocker initiation among young people attending gender services in the United States, United Kingdom and Australia.
• United States: In a four-year study of 926 adolescents just 5.1% commenced puberty blockers.
• United Kingdom: Puberty blockers are now restricted to formal clinical trials.
• Australia: Royal Children’s Hospital (RCH) data indicate that approximately 23–29% of evaluated young people commenced puberty blockers.
If the proposition that 95–98% of those who commence puberty blockers subsequently progress to cross-sex hormones is correct, the substantially higher rate of puberty-blocker initiation reported by RCH would logically imply a correspondingly much higher rate of subsequent cross-sex hormone treatment than that seen in other international gender facilities.
IS RCH TELLING THE TRUTH?
Probably the most serious inherent risk in taking a prepubertal child to a gender clinic for assessment of his/her wish to undergo gender transition.
There are two distinct variables of children in relation to their gender preference as they approach puberty:
• Those who continue to want to change gender at puberty, persisters (PS)
• Those who cease to wish to change their gender as they approach puberty, decisters (DS)
Some 70-90% of children, if left alone, will spontaneously desist as they approach puberty no longer wanting to change their gender.
It would be a disaster for a potential DS to undergo gender transition prior to puberty.
Clearly Gender Physicians must ensure that a child presenting with Gender Dysphoria and seeking Gender Transition is not one of the 70-90% of the cohort that would spontaneously desist as he/she approached puberty.
Obviously, the RCH is aware of the DS,PS cohorts challenfe and claim that they can identify the DS and not commence them in puberty blockers and subsequently cross sex hormones.
That would solve the problem if it were true, however the methodology by which RCH makes these important decisions had not received global acceptance.
• The findings of the Cass Review profoundly challenge the evidentiary basis for the RCH's claimed ability to identify PSers (those who remain trans into adulthood) and DSers (those whose gender confusion resolves).
• Independent psychiatric experts point out that there are zero validated psychological tests, objective biomarkers, or diagnostic tools capable of predicting an individual child’s long-term gender trajectory.